Bone metastases: the current state of knowledge and the prospects for pharmacological treatment.
The management of patients with skeletal metastases includes surgery, palliative radiotherapy and systemic treatment (chemotherapy, hormonotherapy, and the use of bisphosphonates). Hormonotherapy and chemotherapy in the treatment of skeletal metastases are most frequently used in patients with breast and prostate cancer and in patients with myeloma. Bisphosphonates in patients with skeletal metastases from those tumours allow for reduction of skeletal complications and improvement of their life quality.